CD19 / CD20

Assets acting on this target.

Class
Bispecific chimeric antigen receptor (CAR) T-cell therapy targeting CD19 and CD20
Notes
mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT06462144 names the target); source: https://clinicaltrials.gov/study/NCT06462144

← all mechanisms